IontoPatch Technical Overview: Dose, Current & Design

IontoPatch® is a family of single-use, self-contained iontophoresis devices that help deliver a properly chosen soluble ionic medication through intact skin.

Unlike traditional iontophoresis treatments that use a reusable controller, lead wires, and separate electrodes, IontoPatch combines these elements into one wearable system:

• Positive and negative electrode chambers
• Medication and return-solution reservoirs
• Electrochemically active electrode coatings
• A thin internal power source on applicable models
• Skin adhesive and breathable backing
• A predetermined electrical-dose capacity

This technical overview explains how those components interact, what an 80 or 120 mA·min rating actually means, why wear time varies, and how manufacturer test data should be interpreted.

For a plain-language explanation of iontophoresis and medication polarity, read How Does IontoPatch Work?. For product selection, compare the IontoPATCH STAT, IontoPATCH 80, and IontoPatch Extra Strength models.

Technical scope: This page explains the patch’s electrical and electrochemical design. It does not prescribe a medication, polarity, treatment location, or clinical protocol.

IontoPatch Technology at a Glance

IontoPatch is containing both electrode chambers and a self-contained power system. Current begins when the prepared, moistened chambers are applied securely to the body and the skin completes the electrical circuit.

The Basic IontoPatch Electrical Circuit

IontoPatch contains two electrically opposed chambers.

A negatively charged medication is placed in the negative chamber. A positively charged medication is placed in the positive chamber. The electrical field repels the similarly charged medication away from the electrode and toward the skin.

The manufacturer’s principles-of-operation document also states that the two-chamber design is technically capable of holding negatively and positively charged compounds simultaneously. That technical capability should not be interpreted as permission to combine two medications without prescriber and pharmacist review of compatibility, concentration, formulation, dose, and interactions.

What activates the patch?

The patch does not require a conventional power button.

Current begins when:

1. The prescribed medication is placed in the appropriate chamber.
2. Saline is applied to the opposite chamber.
3. Both chambers are brought into secure contact with intact skin.
4. The skin completes the electrical path between the two sides.

The saline contains no active medication. Its purpose is to moisten the return chamber, provide conductive ions, and help complete the circuit.

Detailed preparation and placement instructions belong in an application guide rather than this technical overview. Use How Does IontoPatch Work? for the complete workflow.

What does mA·min mean?

An iontophoresis dose is conventionally expressed in milliamp-minutes, abbreviated mA·min.

Electrical dose = current in milliamperes × treatment time in minutes

For example:

These examples demonstrate the dose calculation only. They are not IontoPatch programming instructions.

A low current delivered for a long period can provide the same total electrical charge as a higher current delivered over a shorter period. This principle is why IontoPATCH STAT and IontoPATCH 80 can both have an 80 mA·min capacity while having substantially different average wear times.

Electrical dose is not medication mass

An 80 mA·min patch does not guarantee that 80 mg, 8 mg, or another fixed medication mass enters the tissue.

Only a portion of the electrical current may be carried by the intended medication ion. Other ions in the medication formulation, saline, skin, and body fluids can also carry a current.

The percentage of current attributable to the intended ion in the delivery efficiency. It depends on the formulation and treatment conditions and is not identical for every drug or patient.

Factors affecting medication transport

Medication movement may be influenced by:

• Ionic charge and valence
• Drug concentration
• Molecular size
• Ionic mobility
• Water solubility
• Formulation pH
• Competing ions
• Fill volume
• Skin resistance
• Skin hydration
• Treatment location
• Sweat-duct density
• Patch adhesion
• Duration of wear
• Individual physiology

The patch is manufactured with a controlled electrical capacity. That should not be described as a direct measurement of the exact number of medication molecules reaching the target tissue.

How the IontoPatch Power System Works

The technical overview describes electrochemically active coatings on the patch electrodes.

The technical reactions are represented as:

Positive electrode: Zn → Zn²⁺ + 2e⁻

Negative electrode: AgCl + e⁻ → Ag + Cl⁻

The known quantities of reactive coating are used during production. As current flows, these coatings are gradually consumed. When their available capacity is depleted, the current falls substantially.

Does the IontoPatch automatically shut off?

The most technically accurate description is that IontoPatch has a self-limiting electrical capacity.

As the electrode coatings are consumed:

1. Available electrochemical material decreases.
2. Current gradually declines.
3. The electrical-dose capacity approaches completion.
4. Current becomes substantially reduced.

This process is sometimes described as an automatic shutoff, but the patch does not directly measure tissue medication concentration or verify that an exact medication mass reached the intended structure. The manufacturer’s principles letter explains that current is suspended when the controlled electrode coatings are depleted.

Why IontoPatch Current Is Not Constant

Skin does not behave like a fixed laboratory resistor. Its electrical resistance varies between people, treatment sites, and even during the same application.

The relationship can be simplified through Ohm’s law:

Voltage = current × resistance

When the available voltage is relatively fixed:

• Higher resistance generally permits less current to flow.
• Lower resistance generally permits more current to flow.
• Lower current usually requires more time to use the available mA·min capacity.
• Higher current may use the available capacity more quickly.

Variables affecting skin resistance

The delivery times are averages rather than guarantees.

Technical Comparison of IontoPatch Models

The complete buyer-oriented comparison already appears on the IontoPatch product page. The table below focuses on the technical relationship among electrical dose, current profile, and wear time.

IontoPATCH STAT and IontoPATCH 80 are not different medication doses merely because they have different wear times. They provide the same labeled electrical capacity using different delivery-rate profiles. Extra Strength increases the electrical capacity to 120 mA·min.

Medication selection, concentration, fill volume, and the amount ultimately reaching tissue remain separate considerations.

Manufacturer Electrical-Performance Testing

The technical overview reports several engineering and feasibility tests. These data describe patch consistency, current behavior, and model-compound transport. They should not be presented as proof that the device produces a specific clinical result for every medication or diagnosis.

Patch-capacity reproducibility

A typical manufacturing lot was tested by discharging patches in saline until current fell to 1% of its peak value.

This test supports the consistency of the manufactured electrical capacity. It does not measure clinical pain relief or the exact medication mass delivered into human tissue.

Human-subject current observation

The manufacturer also reports testing eight 40 mA·min patches loaded with 1% sodium chloride at several body locations.

The data estimate an average current of approximately 0.36 mA for STAT and approximately 0.26 mA for Extra Strength under the stated assumptions. Actual current varies because patient skin resistance and contact conditions are not fixed.

Model-compound delivery testing

The manufacturer reports in vitro and volunteer testing using a negatively charged model compound. Passive movement was subtracted from total movement to estimate the iontophoretic contribution.

These results should be interpreted cautiously:

• A model compound does not represent every prescription medication.
• Laboratory membranes do not duplicate living skin.
• Small feasibility samples do not establish universal delivery efficiency.
• Drug formulation and competing ions can change transport.
• Tissue delivery cannot be inferred solely from residual material left in the patch.
• Technical delivery data do not establish comparative clinical effectiveness.

Clinical-outcome evidence is addressed separately in IontoPatch Research: Clinical Evidence and Study Results.

Electrode Chemistry, pH, and Skin Interface

Traditional iontophoresis systems using chemically inert electrodes may electrolyze water at the electrode surface. That reaction can produce acidic conditions at one electrode and alkaline conditions at the other.

The IontoPatch technical overview states that its reactive zinc and silver-chloride coatings participate in the electrical reaction instead of primarily electrolyzing water. According to the manufacturer, this design:

• Limits water-electrolysis reactions
• Reduces extreme pH changes at the chambers
• Avoids the need for added buffer salts in the patch
• Reduces competition between buffer ions and medication ions
• Maintains lower current densities than limits cited in its technical references

The manufacturer’s pH comparison and current-density calculations are bench and engineering data, not guarantees that irritation cannot occur. Iontophoresis can still produce redness, irritation, discomfort, burns, or medication-related reactions. (IontoPatch)

For practical symptom guidance, read IontoPatch Discomfort: Irritation, Burning, and Removal.

Current Density vs. Total Current

Total current and current density are related but are not the same measurement.

A smaller electrode area carrying the same total current produces a higher current density. Current density is relevant to skin sensation and irritation risk because electrical flow is concentrated over less tissue.

This is one reason patch size, active area, adhesion, and model design should be evaluated together rather than comparing devices solely by mA·min capacity.

IontoPatch vs. Other Iontophoresis Technologies

Wearable patch and controller-based system comparison

A self-contained patch is not inherently better or worse than a controller-based system. The appropriate format depends on the prescribed dose, treatment duration, medication volume, skin tolerance, body location, required monitoring, and clinic workflow.

Technical Safety Boundaries

This page does not reproduce our complete application and safety content, but several limits are central to understanding the technology.

It contraindicates use over damaged or denuded skin and around the orbital region and warns that drugs delivered with the device may cause systemic adverse effects.

Use IontoPatch Discomfort: Irritation, Burning, and Removal for practical response guidance.

Frequently Asked Technical Questions

Does an 80 mA·min patch deliver 80 mg of medication?

No. The mA·min rating measures electrical charge over time. Medication mass transported depends on the formulation, concentration, ionic mobility, competing ions, skin, placement, and other variables.

Is the IontoPatch current fixed?

No. Current varies with skin resistance and treatment conditions. The patch has a controlled electrical capacity, but it does not necessarily deliver one constant current throughout the entire wear period.

Why do two 80 mA·min models have different wear times?

IontoPATCH STAT uses a shorter, higher-average-current delivery profile. IontoPATCH 80 uses a slower, lower-current profile. Both have the same labeled total electrical capacity.

Does IontoPatch contain medication when purchased?

No. Medication is supplied separately and added according to the prescriber’s direction. Saline is an activation and return solution, not the active medication.

Does the patch use an ordinary coin-cell battery?

The power system is integrated into the patch and combines electrochemically active electrode coatings with an additional thin battery on applicable designs. The manufacturer describes approximately one volt from the coatings and up to three additional volts from the integrated battery.

How does the patch know the treatment is complete?

It does not measure tissue medication levels. Controlled electrode materials are consumed as current flows, causing current to decline as the patch’s electrical capacity is exhausted.

Does slower delivery mean less electrical dose?

Not necessarily. IontoPATCH 80 and STAT both provide an electrical capacity of 80 mA·min. IontoPATCH 80 spreads that capacity over a longer average period.

Is all medication loaded into the chamber transported through the skin?

No. Some medication may remain in the patch, some may move passively, and only a portion may be transported by iontophoresis. Delivery efficiency varies with the compound and treatment conditions.

Can a neutral compound be delivered by IontoPatch?

Simple electrorepulsion depends on ionic charge. The manufacturer specifically warns against using non-ionic acetic acid and iodine because they will not be effectively driven by iontophoresis and may irritate the skin. The exact formulation must be confirmed rather than inferred from a similar chemical name.

Is the average wear time the maximum time the patch should remain on?

Not necessarily. Average dose-delivery time and the manufacturer’s removal limit are different concepts. Follow the current package instructions and clinician direction for the exact model.

Does IontoPatch prove that medication penetrates one centimeter in every treatment?

No. The technical overview cites prior iontophoresis literature reporting penetration to at least approximately one centimeter in certain contexts. That should not be converted into a guarantee for every medication, body site, or patient.

Is a higher-dose patch always more effective?

No. A higher electrical capacity is not automatically the correct choice. Patch selection depends on the prescribed dose, formulation, treatment site, skin tolerance, and clinical objective.

Related IontoPatch Resources

Use the page that matches the question rather than duplicating the information here:

This technical overview describes device design and manufacturer-reported engineering data. It does not prescribe medication, establish medication compatibility, or guarantee a specific clinical outcome.